China SXT Pharmaceuticals Announces $12M Registered Direct Offering

Key Facts

1China SXT Pharmaceuticals entered an agreement to sell 8 million Class A ordinary shares at $1.50 per share.

2The company will also issue 8 million warrants with an exercise price of $1.50 per share.

China SXT Pharmaceuticals entered an agreement to sell 8 million Class A ordinary shares at a price of $1.50 per share. PR Newswire reported that the company will also issue 8 million warrants with an exercise price of $1.50 per share, aiming to raise gross proceeds of approximately $12 million.

The offering follows a session where SXTC closed at $2.83 on October 7, 2026, indicating the direct offering price is at a discount to recent closing levels. The stock experienced significant volatility on October 7, 2026, trading between a day low of $1.87 and a day high of $9.59.